Ravi C Dara Shares WHO’s Phase A guidance for PBM from ISBT
Ravi C Dara, Consultant Physician Transfusion medicine at Sheikh Shakhbout Medical City, reposted from ISBT on LinkedIn:
”Better outcomes, fewer transfusions – Optimizing outcomes while reducing transfusions – WHO‘s Phase A guidance is here”
Quoting International Society of Blood Transfusion (ISBT)‘s post:
”The Patient Blood Management subgroup of the ISBT Clinical Transfusion Working Party is dedicated to spreading awareness on PBM and to help support its wider implementation.
This week, we’re shining a light on Patient Blood Management (PBM) and each day, we’ll explore a different phase of the PBM system, sharing diverse perspectives on who can benefit from it.
Patient blood management (PBM) is a new paradigm to manage and preserve an individual’s own blood in health and illness and highlighted as a patient-centered approach aimed at improving patient outcomes with reduced morbidity, mortality and length of hospital stay.
For Day 1, we’re highlighting Phase A of the WHO Implementation Guidance, focusing on the aims and initial steps involved in establishing PBM within healthcare settings.”
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 11:42Tasmin Hassan: Explainable AI for Anemia Severity Prediction at IEEE SPICSCON 2026
-
Aug 15, 2026, 11:36Ana Sachetto: Challenges in Extracellular Vesicle Analysis by Flow Cytometry
-
Aug 15, 2026, 11:20Saifur Rahman Chowdhury: Guidelines for Managing Critical Bleeding in ITP
-
Aug 15, 2026, 10:16Tracy Cen: Sharper Portal Venous Imaging for Precise Veterinary Diagnosis
-
Aug 15, 2026, 09:54Ryan Noik: Transforming Coagulation Care Through Precision Diagnostics
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring